national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference
national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference
national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference
national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference
national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference
national disclosure summit on Pharmaceutical and Medical Device Disclosure, Transparency and Aggregate Spend Conference



Overview | Agenda | Promotional Opportunities | Grantors & Exhibitors
Speaking Proposals | Administration | Past Events | Webcast Log In | Contact Us | Home



THE FIFTH NATIONAL DISCLOSURE SUMMIT CONTENT IS NOW AVAILABLE
IN VARIOUS POST CONFERENCE FORMATS

The Fifth National Disclosure Summit conference content is now available in a variety of formats.

You may purchase the Summit streaming content in the following formats: Flash Drive or online archive (6 months). You may also purchase individual presentations in an online archive (6 months) format.

YOU CAN PURCHASE JUST THE FIFTH NATIONAL DISCLOSURE SUMMIT CONTENT AS FOLLOWS:

Online Archive of 2013 Fifth National Disclosure Summit Presentations today!
Complete conference: $595
Order Now

Flash Drive of 2013 Fifth National Disclosure Summit Presentations today!
$595
Order Now

FINALLY YOU MAY PURCHASE THE FIFTH NATIONAL DISCLOSURE SUMMIT INDIVIDUAL PRESENTATIONS:
Click here to purchase individual presentations for $59.95 in online archive format (6 months of access - 24/7).




national pharmaceutical and medical device disclosure and transparency conference

FIFTH ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES

With Special Sessions on Domestic and Global Transparency Initiatives

February 19 - 21, 2013

Onsite:
The Ritz-Carlton
Washington, DC


Online:
Live and Archived for 6 Months

MEDIA PARTNERS

SPONSORED BY

FOLLOW US ON




DISCLOSURE SUMMIT IS
NEWLY CONFIRMED KEYNOTE SPEAKER

Niall Brennan
Director, Office of Information Products and Data Analytics, Centers for Medicare and Medicaid Services, Washington, DC

CMS ISSUES SUNSHINE RULE
CMS issued the sunshine rule on Friday, February 1. The rule is scheduled for publication in the Federal Register on February 8. Click here.

SPECIAL PCF REGISTRATION DISCOUNT
Click here for Special Pharmaceutical Compliance Association Member Registration Discount.

BROCHURE NOW AVAILABLE
Click here to download brochure.

TUITION SCHOLARSHIPS
The Disclosure Summit is now offering partial and full Tuition Scholarships to qualifying representatives of local, state and federal government, consumer advocate organizations, safety net providers, academics, students and health services research organizations.
Click here for more information.

GRANTORS
DIAMOND
GOLD
BRONZE





























FIFTH ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND
AGGREGATE SPEND FOR DRUG, DEVICE AND BIOTECH COMPANIES

With Special Sessions on Domestic and Global Transparency Initiatives

A Pharma Congress Conference
February 19 - 21, 2013

ONSITE
The Ritz-Carlton
Washington, DC


OR
ONLINE
In your own office or home live via the Internet
with 24/7 access for six months


CO CHAIRS

Katrina S. Cahill
Senior Manager, Global Transparency Lead, Biogen Idec, Weston, MA

Rore Middleton, Esq.
Senior Manager, Corporate Compliance, Purdue Pharma LP, Stamford, CT

Trudy J. Seeley
Senior Manager, Transparency Operations, Sanofi US, Bridgewater, NJ
PRECONFERENCE: SUNSHINE ACT, DOMESTIC AND GLOBAL AGGREGATE SPEND AND DISCLOSURE 101

Jae Burnett
Senior Manager, Deloitte & Touche LLP, Costa Mesa, CA

Danielle M. Drissel, Esq.
Associate, Hogan Lovells US LLP, Washington, DC

Sally Foroughi
Senior Manager, Deloitte & Touche LLP, Costa Mesa, CA

Gus Papandrikos
Director Transparency Operations, sanofi-aventis, New York, NY

Jack T. Tanselle
Managing Director, Navigant Consulting, Inc., Indianapolis, IN

Ronald L. Wisor, Jr. Esq.
Partner, Hogan Lovells US LLP, Washington, DC
FEATURING ENFORMCEMENT UPDATE BY

Virginia "Ginny" A. Gibson, Esq.
Partner, Hogan Lovells US LLP, Former Executive Assistant US Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA

David Hart, Esq.
Senior Assistant Attorney General, Oregon Department of Justice, Salem, OR

Michael K. Loucks, Esq.
Partner, Skadden Arps LLP, Former First Assistant US Attorney, US Attorney's Office for the District of Massachusetts, Washington, DC

Marilyn May, Esq.
Deputy Chief for Affirmative Litigation, US Attorney's Office, Eastern District of Pennsylvania, United States Department of Justice, Philadelphia, PA
IMPLICATIONS FOR PHARMA AND PHYSICIANS

Michaeline Daboul
President and Chief Executive Officer, MMIS, Inc. New York, NY

Jeremy A. Lazarus, MD
Board-certified Psychiatrist, President, American Medical Association, Denver, CO

David J. Rothman, PhD
Director, Center for the Study of Society and Medicine, Bernard Schoenberg Professor of Social Medicine, College of Physicians and Surgeons, Columbia University, President, Institute on Medicine as a Profession, New York, NY

STATE DISCLOSURE
LAW UPDATE

Natasha F. Thoren, JD, LLM
Associate, Pharmaceutical Industry Health, Regulatory Practice Group, Epstein Becker & Green, New York, NY

DEALING WITH
THE CONSEQUENCES

Seth H. Lundy, Esq.
Partner and Deputy Chair, FDA and Life Sciences Practice Group, King & Spalding, Washington, DC

FRAUD AND
ABUSE RISKS

Meenakshi Datta, Esq.
Partner, Sidley Austin LLP, Chicago, IL


DEALING WITH
THE CONSEQUENCES

Seth H. Lundy, Esq.
Partner and Deputy Chair, FDA and Life Sciences Practice Group, King & Spalding, Washington, DC

FRAUD AND
ABUSE RISKS

Meenakshi Datta, Esq.
Partner, Sidley Austin LLP, Chicago, IL

GLOBAL TRANSPARENCY UPDATE

Ronny Arijs
Vice President Global Sustainability and Chief Compliance Officer, Grunenthal, Member, EFPIA Compliance Workgroup, Former Senior Compliance Manager, GE Healthcare, Brussels, Belgium

J. Mark Farrar, CPA, CFE, CFF
Associate Director, Navigant Consulting, Inc., Atlanta, GA

Bharathram Lakshmivarahan
Manager, Pharmaceutical and Life Sciences Advisory Services, PwC, Philadelphia, PA

Evelyne Lemaire
Director, Global Pharmaceutical and LIfe Sciences, PwC LLP, Zurich, Switzerland

Michael McNeal
Director, Pharmaceutical and Life Sciences Advisory Services, PwC, Denver, CO

Jason Staples, Esq.
Senior Counsel, International Legal Operations, Abbott Laboratories, Chicago, IL

Heloisa Barroso Uelze
Head, Brazilian Public Law, Government Relations and Regulatory Group, Trench, Rossi e Watanabe, São Paulo, Brazil

David Wysocky
Director, Pharmaceutical and Life Sciences Advisory Services, PricewaterhouseCoopers, Florham Park, NJ

Sarah Volden
Manager, Pharmaceutical and Life Sciences Advisory Services, PwC, Los Angeles, CA

Kevin Yamaga-Karns, Esq.
Senior Director, Legal and Compliance, Eli Lilly Japan, Hyogo, Japan
NEW DEVELOPMENTS IN DISCLOSURE, ANTICORRUPTION AND FCPA ENFORCEMENT

Michael D. Bell, Esq.
President, R-Squared, Princeton, NJ

Nate Hwang
Compliance Officer and Senior Healthcare Counsel, Americas, Zimmer Holdings, Warsaw, IN

Kelly N. "Nikki" Reeves, MPA, JD
Partner, King & Spalding LLP, Washington, DC

Christopher D. Zalesky
Johnson & Johnson World Headquarters, New Brunswick, NJ
DRUG SAMPLE DISCLOSURE

John Patrick Oroho, Esq.
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ

Marjorie Powell
Senior Assistant General Counsel, PhRMA, Washington, DC
R&D AND CLINICAL TRIALS

Diane Bieri, Esq.
Partner, Arnold & Porter LLP, Former Executive Vice President and General Counsel, PhRMA, Washington, DC

Seth Whitelaw, JD, LLM, SJD
Director, Life Sciences Regulatory Compliance Practice, Deloitte & Touche LLP, Former R&D Compliance Officer, GlaxoSmithKline, Former Legal Compliance Officer, SmithKline Beecham Pharmaceuticals, Philadelphia, PA

Kim Zahan, MBA
Director R&D Financial Compliance, GlaxoSmithKline, King of Prussia, PA
AGG SPEND 201 - 301: BEYOND THE BASICS

Marc Adler, Esq.
Director, Compliance Consulting, R-Squared Services and Solutions, Inc., Princeton, NJ

Michael D. Bell, Esq.
President, R-Squared, Princeton, NJ




Christine Gordon, Esq.
Executive Director of Compliance, Olympus America, Inc., Center Valley, PA

Stacy Hornaday
Assistant Compliance Director, Astellas Pharmaceuticals, Chicago, IL

Amy Padgett
Senior Marketing Manager, Concur Connect Platform, Concur Technologies, Alexandria, VA
ADVANCED IMPLEMENTATION ISSUES

Mark Linver
Managing Director, Life Sciences Advisory Services Practice, Huron Consulting Group, LLC, New York, NY

Suj Patel
Director, Life Sciences Practice, Huron Consulting Group, New York, NY
GLOBAL HCP CONTRACTING AND DATA COLLECTION

Andy Bender, MS, MBA
President, Polaris, New York, NY

Ben Carmel, MS
Manager, Polaris, New York, NY



Elize Hurry, LLB
Business Conduct Specialist II, Gilead Sciences Inc., Foster City, CA

Gayla M. Sorenson
Director of Global Medical Compliance Operations, Biomet, Inc., Warsaw, IN
FAIR MARKET VALUE

Mark A. DeWyngaert, MBA, PhD
Managing Director, Huron Consulting Group, New York, NY

Jen Johnson, CFA
Partner, VMG Health, Dallas, TX
AGGREGATE SPEND FOR SMALL AND MID-SIZED COMPANIES

Danielle Bacco
Manager, Corporate Compliance, Purdue Pharma LP, Stamford, CT

Jennifer McGee, Esq.
Senior Compliance Counsel, Otsuka America Pharmaceutical Inc., Rockville, MD

Wendy Tsuei, MBA
Associate Director, Aggregate Spend, Corporate Ethics and Compliance, Eisai Co., Ltd., Woodcliff Lake, NJ

Christine N. Bradshaw, Esq.
Director of Regulatory and Compliance Services, Porzio Life Sciences, LLC, Associate, Porzio, Bromberg & Newman PC, Morristown, NJ (Moderator)

ATTENDANCE OPTIONS
TRADITIONAL CONFERENCE ATTENDANCE
By attending onsite, you will be able to more completely immerse in the subject matter, get professional networking opportunities, and interact with the faculty. Register for Preconference and/or Conference.

LIVE AND ARCHIVED INTERNET ATTENDANCE
Watch the conference plenary session in live streaming video and listen to streaming audio of track sessions over the Internet and at your convenience at any time 24/7 for the six months following the event.

The archived conference includes speaker videos and coordinated PowerPoint presentations.

Pros: Live digital feed and 24/7 Internet access for next six months; Accessible in office, at home or anywhere worldwide with Internet access; Avoid travel expense and hassle; No time away from the office

INTERNET INTERFACE SAMPLE

Click here for a sample stream





SAVE THE DATES

FIFTH ANNUAL SUMMIT ON DISCLOSURE, TRANSPARENCY AND AGGREGATE SPEND
A Hybrid Conference and Internet Event
February 19 - 21, 2013
The Ritz-Carlton
Washington, DC
www.DisclosureSummit.com
SEVENTH INTERNATIONAL PHARMACEUTICAL COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by International Society of Healthcare Compliance Professionals
Cosponsored by Pharmaceutical Compliance Forum
May 21 - 23, 2013
Meliá Castilla Hotel
Madrid, Spain
www.InternationalPharmaCongress.com
THIRD ASIA PACIFIC PHARMACEUTICAL
COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by Pharmaceutical Compliance Forum
Media Partners: Life Science Compliance and RX Compliance Report
September 10 - 12, 2013
Kuala Lampur, Malaysia
www.AsianPharmaCongress.com
FOURTEENTH PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum
October 28 - 30, 2013
Hyatt Regency on Capitol Hill
Washington, DC
www.PharmaCongress.com

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.





Overview | Agenda | Promotional Opportunities | Grantors & Exhibitors
Speaking Proposals | Administration | Past Events | Webcast Log In | Contact Us | Home




© Health Care Conference Administrators
Contact Webmaster
line_horiz.gif" BORDER=0 WIDTH=100% HEIGHT=1>


© Health Care Conference Administrators
Contact Webmaster